Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 31, 2006. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons regarding the company's ordinary shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The material change reported is a transfer of 88,183 Ordinary Shares from the GlaxoSmithKline Employee Trust ("the GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991. This transaction occurred on August 29, 2006, and was advised to the company on August 31, 2006.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on business strategy, or discussion of risks and contingencies. It notes that the GSK Trust is a discretionary trust for current and former employees, and three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) are interested in the shares held in the trust similarly to other employees.
Key Facts for Investor Verification
- 88,183 Ordinary Shares were transferred from the GSK Trust to employee plan participants on August 29, 2006.
- Three directors hold an interest in the GSK Trust shares as potential beneficiaries alongside other employees.
- This filing does not contain financial results; investors should refer to Form 20-F or quarterly reports for financial metrics.